Wedmont Private Capital Roivant Sciences Ltd. Transaction History
Wedmont Private Capital
- $1.88 Billion
- Q4 2024
A detailed history of Wedmont Private Capital transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Wedmont Private Capital holds 11,295 shares of ROIV stock, worth $125,713. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,295Holding current value
$125,713% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
318Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$734 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$732 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$602 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$464 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$394 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.84B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...